International law firm Clifford Chance announced today that Nelson Jung is to join the firm’s leading global Antitrust practice as a partner, based in the London office.
Nelson joins from the Competition and Markets Authority (CMA) where he is the Director of Mergers Group. He previously held a number of senior positions at the CMA’s predecessor, The Office of Fair Trading, including Director of Competition Enforcement and Head of Mergers. At the CMA, Nelson has overseen the CMA’s merger caseload and has led on the CMA’s position on EU merger policy. He also represented the CMA in significant mergers that are notified with the European Commission insofar as they give rise to potential issues in the UK, including GE on its acquisition of Alstom and recent transactions in the telecoms sector. He has also played a leading role in shaping the CMA’s role and contributions in the context of the European Commission’s Digital Single Market agenda.
Most recently, Nelson took the lead role in the CMA’s assessment of Muller’s acquisition of Dairy Crest, a case that had originally been notified with the European Commission. He also oversaw the CMA’s recent conditional merger control clearance of the InterCity East Coast rail franchise award and led the merger control assessment of Greene King’s acquisition of Spirit Pub Company.
Nelson Jung is a qualified lawyer in Germany as well as a solicitor in England and Wales. He began his career at Clifford Chance, where he spent six years developing his practice in the firm’s London Antitrust group.
Full Content: Legal Monitor
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas